Trial Profile
A phase I study of XEN D0101 for the prevention of atrial fibrillation.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Sep 2011
Price :
$35
*
At a glance
- Drugs XEN D0101 (Primary)
- Indications Atrial fibrillation
- Focus Adverse reactions
- 30 Nov 2006 New trial record.